Weize Huang

593 total citations
29 papers, 341 citations indexed

About

Weize Huang is a scholar working on Oncology, Pharmacology and Molecular Biology. According to data from OpenAlex, Weize Huang has authored 29 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 10 papers in Pharmacology and 9 papers in Molecular Biology. Recurrent topics in Weize Huang's work include Pharmacogenetics and Drug Metabolism (10 papers), Drug Transport and Resistance Mechanisms (7 papers) and Pharmacological Effects and Toxicity Studies (6 papers). Weize Huang is often cited by papers focused on Pharmacogenetics and Drug Metabolism (10 papers), Drug Transport and Resistance Mechanisms (7 papers) and Pharmacological Effects and Toxicity Studies (6 papers). Weize Huang collaborates with scholars based in United States, Switzerland and Egypt. Weize Huang's co-authors include Nina Isoherranen, Lindsay C. Czuba, Isabelle Ragueneau‐Majlessi, Jennifer E. Sager, Mariko Nakano, Traci Topping, Peter Stefanov Kourtev, Dale Miles, Gabriel Ghiaur and Joan G. Ehrenfeld and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Scientific Reports.

In The Last Decade

Weize Huang

28 papers receiving 340 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Weize Huang United States	13	125	106	89	60	30	29	341
Juliane Riha Austria	10	125 1.0×	189 1.8×	59 0.7×	44 0.7×	40 1.3×	12	392
Choon‐Myung Lee United States	11	126 1.0×	82 0.8×	147 1.7×	28 0.5×	20 0.7×	25	336
Hanna Larsson Sweden	5	135 1.1×	126 1.2×	120 1.3×	24 0.4×	21 0.7×	10	379
Lindsay C. Czuba United States	10	200 1.6×	112 1.1×	40 0.4×	36 0.6×	46 1.5×	21	374
Hyung-Lae Lee South Korea	13	370 3.0×	98 0.9×	62 0.7×	40 0.7×	18 0.6×	35	702
Alessia Francesca Mozzi Italy	9	184 1.5×	119 1.1×	49 0.6×	66 1.1×	47 1.6×	12	476
Liuh Ling Goh Singapore	11	80 0.6×	36 0.3×	43 0.5×	25 0.4×	14 0.5×	28	299
Udom Chantharaksri Thailand	13	86 0.7×	32 0.3×	36 0.4×	63 1.1×	29 1.0×	29	399
Yoshiteru Kamiyama Japan	9	120 1.0×	88 0.8×	111 1.2×	57 0.9×	21 0.7×	9	331
Svetlana Markova United States	3	122 1.0×	196 1.8×	98 1.1×	94 1.6×	28 0.9×	6	416

Countries citing papers authored by Weize Huang

Since Specialization

Citations

This map shows the geographic impact of Weize Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weize Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weize Huang more than expected).

Fields of papers citing papers by Weize Huang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weize Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weize Huang. The network helps show where Weize Huang may publish in the future.

Co-authorship network of co-authors of Weize Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Weize Huang. A scholar is included among the top collaborators of Weize Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weize Huang. Weize Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Stader, Felix, et al.. (2025). Utilizing Minimal Physiologically Based Pharmacokinetic Modeling to Bridge Bevacizumab Pharmacokinetics from Adult to Pediatric Patients. The AAPS Journal. 28(1). 15–15.

Huang, Weize, et al.. (2025). A review of physiologically based pharmacokinetic modeling of renal drug disposition. Drug Metabolism and Disposition. 53(3). 100042–100042. 1 indexed citations

Joslyn, Louis R., Weize Huang, Dale Miles, Iraj Hosseini, & Saroja Ramanujan. (2024). Digital twins elucidate critical role of Tscm in clinical persistence of TCR-engineered cell therapy. npj Systems Biology and Applications. 10(1). 11–11. 11 indexed citations

Huang, Weize, et al.. (2024). A Comparative Clinical Pharmacology Analysis of FDA‐Approved Targeted Covalent Inhibitors vs. Reversible Inhibitors in Oncology. Clinical Pharmacology & Therapeutics. 116(5). 1198–1206. 2 indexed citations

Noorani, Behnam, Rajeev Menon, Xin Chen, et al.. (2023). Venetoclax pharmacokinetics in participants with end‐stage renal disease undergoing haemodialysis. British Journal of Clinical Pharmacology. 90(3). 748–758. 2 indexed citations

Vary, Jay C., Lindsay C. Czuba, Sara Shum, et al.. (2023). Effect of isotretinoin on CYP2D6 and CYP3A activity in patients with severe acne. British Journal of Clinical Pharmacology. 90(3). 759–768. 1 indexed citations

Badawi, Mohamed, Sathej Gopalakrishnan, Weize Huang, et al.. (2023). Venetoclax in biomarker‐selected multiple myeloma patients: Impact of exposure on clinical efficacy and safety. Hematological Oncology. 42(1). e3222–e3222. 4 indexed citations

Czuba, Lindsay C., Karan Malhotra, Emily Fay, et al.. (2023). CYP2D6 Activity Is Correlated with Changes in Plasma Concentrations of Taurocholic Acid during Pregnancy and Postpartum in CYP2D6 Extensive Metabolizers. Drug Metabolism and Disposition. 51(11). 1474–1482. 2 indexed citations

Huang, Weize, et al.. (2023). Predicting complex kidney drug handling using a physiologically‐based pharmacokinetic model informed by biomarker‐estimated secretory clearance and blood flow. Clinical and Translational Science. 17(1). e13678–e13678. 4 indexed citations

10.

Chang, Shih‐Yu, Weize Huang, Alenka Chapron, et al.. (2023). Incorporating Uremic Solute-mediated Inhibition of OAT1/3 Improves PBPK Prediction of Tenofovir Renal and Systemic Disposition in Patients with Severe Kidney Disease. Pharmaceutical Research. 40(11). 2597–2606. 6 indexed citations

11.

Huang, Weize, Felix Stader, Phyllis Chan, et al.. (2022). Development of a pediatric physiologically-based pharmacokinetic model to support recommended dosing of atezolizumab in children with solid tumors. Frontiers in Pharmacology. 13. 974423–974423. 6 indexed citations

12.

Huang, Weize, Lindsay C. Czuba, Jennifer A. Manuzak, et al.. (2021). Objective Identification of Cannabis Use Levels in Clinical Populations Is Critical for Detecting Pharmacological Outcomes. Cannabis and Cannabinoid Research. 7(6). 852–864. 4 indexed citations

13.

Imaoka, Tomoki, Weize Huang, Sara Shum, et al.. (2021). Bridging the gap between in silico and in vivo by modeling opioid disposition in a kidney proximal tubule microphysiological system. Scientific Reports. 11(1). 21356–21356. 21 indexed citations

14.

Samineni, Divya, Weize Huang, Leonid Gibiansky, et al.. (2021). Population Pharmacokinetics and Exposure–Response Analyses for Venetoclax in Combination with R-CHOP in Relapsed/Refractory and Previously Untreated Patients with Diffuse Large B Cell Lymphoma. Advances in Therapy. 39(1). 598–618. 9 indexed citations

15.

Huang, Weize, Lindsay C. Czuba, & Nina Isoherranen. (2020). Mechanistic PBPK Modeling of Urine pH Effect on Renal and Systemic Disposition of Methamphetamine and Amphetamine. Journal of Pharmacology and Experimental Therapeutics. 373(3). 488–501. 14 indexed citations

16.

Huang, Weize & Nina Isoherranen. (2020). Novel Mechanistic PBPK Model to Predict Renal Clearance in Varying Stages of CKD by Incorporating Tubular Adaptation and Dynamic Passive Reabsorption. CPT Pharmacometrics & Systems Pharmacology. 9(10). 571–583. 15 indexed citations

17.

Czuba, Lindsay C., Xia Wu, Weize Huang, et al.. (2020). Altered vitamin A metabolism in human liver slices corresponds to fibrogenesis. Clinical and Translational Science. 14(3). 976–989. 27 indexed citations

18.

Huang, Weize & Nina Isoherranen. (2019). Sampling Site Has a Critical Impact on Physiologically Based Pharmacokinetic Modeling. Journal of Pharmacology and Experimental Therapeutics. 372(1). 30–45. 15 indexed citations

19.

Zhong, Guo, Cathryn A. Hogarth, Jessica M. Snyder, et al.. (2019). The retinoic acid hydroxylase Cyp26a1 has minor effects on postnatal vitamin A homeostasis, but is required for exogenous atRA clearance. Journal of Biological Chemistry. 294(29). 11166–11179. 28 indexed citations

20.

Huang, Weize, Mariko Nakano, Jennifer E. Sager, Isabelle Ragueneau‐Majlessi, & Nina Isoherranen. (2017). Physiologically Based Pharmacokinetic Model of the CYP2D6 Probe Atomoxetine: Extrapolation to Special Populations and Drug-Drug Interactions. Drug Metabolism and Disposition. 45(11). 1156–1165. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact